| 37506543 | Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma. | | 2023 |
| 37819944 | Lenvatinib, toripalimab plus FOLFOX chemotherapy in hepatocellular carcinoma patients with extrahepatic metastasis: A biomolecular exploratory, phase II trial (LTSC). | | 2023 |
| 37579711 | Overexpression of CD99 is associated with tumor adaptiveness and indicates the tumor recurrence and therapeutic responses in gliomas. | | 2023 |
| 37884999 | The Quartet Data Portal: integration of community-wide resources for multiomics quality control. | Genome Biol | 2023 |
| 36968580 | assembly of a chromosome-level reference genome of the ornamental butterfly based on nanopore sequencing and Hi-C analysis. | | 2023 |
| 36778023 | PAnno: A pharmacogenomics annotation tool for clinical genomic testing. | | 2023 |
| 37082656 | NDRG2 regulates the formation of reactive astrocyte-derived progenitor cells Notch signaling pathway after brain traumatic injury in rats. | | 2023 |
| 36931163 | Hepatic arterial infusion chemotherapy for patients with hepatocellular carcinoma: Applicability in Western countries. | | 2023 |
| 35051757 | Bisphenol F suppresses insulin-stimulated glucose metabolism in adipocytes by inhibiting IRS-1/PI3K/AKT pathway. | Ecotoxicology and Environmental Safety | 2022 |
| 36310597 | Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: A workshop report. | Front Mol Biosci | 2022 |
| 36310160 | One day versus two days of hepatic arterial infusion with oxaliplatin and fluorouracil for patients with unresectable hepatocellular carcinoma. | BMC Medicine | 2022 |
| 35844495 | Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma. | Frontiers in Immunology | 2022 |
| 35768876 | Deep oncopanel sequencing reveals within block position-dependent quality degradation in FFPE processed samples. | Genome Biol | 2022 |
| 36097402 | Differential expression of hepatic cancer stemness and hypoxia markers in residual cancer after locoregional therapies for hepatocellular carcinoma. | Hepatology Communications | 2022 |
| 35387338 | Transcriptome Changes and Potential Immunotoxicity Analysis in RAW264.7 Macrophages Caused by Bisphenol F. | Frontiers in Pharmacology | 2022 |
| 36153392 | A comprehensive genomic and transcriptomic dataset of triple-negative breast cancers. | Scientific data | 2022 |
| 35879681 | Gut microbiome changes in anti-N-methyl-D-aspartate receptor encephalitis patients. | BMC Neurology | 2022 |
| 36270084 | Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer. | Breast | 2022 |
| 35551205 | Comprehensive microRNA-seq transcriptomic profiling across 11 organs, 4 ages, and 2 sexes of Fischer 344 rats. | Scientific data | 2022 |
| 35410795 | Corrigendum to "Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-κB pathways in experimental autoimmune myositis mice" [Biochem. Biophys. Res. Commun. 603(2022) 29-34]. | Biochemical and Biophysical Research Communications | 2022 |
| 35981413 | Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial. | European Journal of Cancer | 2022 |
| 35919459 | Comprehensive characterization of enhancer RNA in hepatocellular carcinoma reveals three immune subtypes with implications for immunotherapy. | Molecular Therapy - Oncolytics | 2022 |
| 35782729 | BioVisReport: A Markdown-based lightweight website builder for reproducible and interactive visualization of results from peer-reviewed publications. | Computational and Structural Biotechnology Journal | 2022 |
| 36529949 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials. | | 2022 |
| 36455201 | Cell Infiltrative Inner Connected Porous Hydrogel Improves Neural Stem Cell Migration and Differentiation for Functional Repair of Spinal Cord Injury. | ACS Biomaterials Science and Engineering | 2022 |
| 35316070 | Reply to J. Mei et al. | Journal of Clinical Oncology | 2022 |
| 35276460 | Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-κB pathways in experimental autoimmune myositis mice. | Biochemical and Biophysical Research Communications | 2022 |
| 34980216 | Assessing reproducibility of inherited variants detected with short-read whole genome sequencing. | Genome Biol | 2022 |
| 34648352 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial. | Journal of Clinical Oncology | 2022 |
| 35342396 | Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma. | Journal of Oncology | 2022 |
| 34930391 | Hidden biases in germline structural variant detection. | Genome Biol | 2021 |
| 32049678 | Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection. | European Journal of Gastroenterology and Hepatology | 2021 |
| 33907695 | Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models. | | 2021 |
| 33854567 | Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy lenvatinib alone for advanced hepatocellular carcinoma. | Therapeutic Advances in Medical Oncology | 2021 |
| 33634987 | Forty-three key gene expressions involved in the effect of indoleamine 2,3-dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3-dioxygenase 1 inhibitor biomarker. | Clinical and Translational Medicine | 2021 |
| 34166806 | Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score-Matching Analysis. | Journal of Vascular and Interventional Radiology | 2021 |
| 34055599 | Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma. | Frontiers in Oncology | 2021 |
| 34054530 | Investigation of the Multi-Target Mechanism of Guanxin-Shutong Capsule in Cerebrovascular Diseases: A Systems Pharmacology and Experimental Assessment. | Frontiers in Pharmacology | 2021 |
| 33791252 | Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma. | | 2021 |
| 33519205 | Evaluation of Antiemetic Therapy for Hepatic Arterial Infusion Chemotherapy with Oxaliplatin, Fluorouracil, and Leucovorin. | Therapeutics and Clinical Risk Management | 2021 |
| 33933153 | Functional consequences of a rare missense BARD1 c.403G>A germline mutation identified in a triple-negative breast cancer patient. | Breast Cancer Research | 2021 |
| 34092242 | A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD). | Cancer Cell International | 2021 |
| 33718175 | Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma. | Frontiers in Oncology | 2021 |
| 33557607 | Ginkgolide B promotes oligodendrocyte precursor cell differentiation and survival via Akt/CREB/bcl-2 signaling pathway after white matter lesion. | Experimental Biology and Medicine | 2021 |
| 33863366 | A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency. | Genome Biol | 2021 |
| 33863344 | Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions. | Genome Biol | 2021 |
| 33813646 | Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis. | Cancer Immunology, Immunotherapy | 2021 |
| 34794449 | Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro. | Cancer Cell International | 2021 |
| 34736145 | Cell-adaptable dynamic hydrogel reinforced with stem cells improves the functional repair of spinal cord injury by alleviating neuroinflammation. | Biomaterials | 2021 |
| 34671549 | Unique Genomic Alterations of Cerebrospinal Fluid Cell-Free DNA Are Critical for Targeted Therapy of Non-Small Cell Lung Cancer With Leptomeningeal Metastasis. | Front Oncol | 2021 |